Boston Type II Keratoprosthesis, 7 Years of Experience and Outcomes From a Spanish Tertiary Eye Care Hospital.

Am J Ophthalmol

From the Department of Ophthalmology (A.O.B., C.S.E., A.S.C., R.F.L., N.A.V., J.E.E.), BioCruces Bizkaia Health Research Institute, University Hospital of Cruces, Barakaldo, Spain; Department of Cell Biology and Histology (N.A.V., J.E.E.), School of Medicine and Nursing, University of the Basque Country, Leioa, Spain.

Published: January 2025

Purpose: To report midterm outcomes of Boston Keratoprosthesis type II at a reference center in Spain.

Design: Retrospective case series.

Methods: This observational study included medical records of 9 patients who underwent Boston Keratoprosthesis type II surgery at Cruces University Hospital from May 2016 through May 2023. A total of 9 eyes received this device during the study period. One patient who had undergone a modification of the standard procedure was excluded. Preoperative and postoperative parameters were studied. The main outcomes analyzed were visual acuity, device retention, and complications and their management.

Results: The most common indication for implantation was severe Sjögren syndrome (33.3%) followed by graft-versus-host disease (22.2%). The mean follow-up was 3.89 years (±2.08). Visual acuity improved to better than or equal to 20/40 in 8 eyes (88.8%) and 20/25 in 6 eyes (66.6%), while best-corrected visual acuity of 20/20 was achieved in 4 eyes (44.4%). At the last visit, maximum visual acuity was maintained in 4 patients. The most common postoperative complication was retroprosthetic membrane formation (77.7%). New-onset glaucoma was detected in 4 patients (44.4%). Device extrusion occurred in 1 eye and 2 more patients required replacement surgery. All but 1 of the patients are on postoperative treatment with systemic immunosuppressants.

Conclusions: The Boston type II Keratoprosthesis is a useful option for visual rehabilitation in end-stage ocular surface diseases. Multidisciplinary management of complications is of vital importance for the maintenance of vision and the device. Immunosuppressive treatment helps control the inflammation that leads to most associated complications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajo.2024.08.010DOI Listing

Publication Analysis

Top Keywords

visual acuity
16
boston type
8
type keratoprosthesis
8
boston keratoprosthesis
8
keratoprosthesis type
8
patients
5
visual
5
boston
4
keratoprosthesis
4
keratoprosthesis years
4

Similar Publications

Purpose: A performance comparison of two myopia control spectacle lens designs, defocus incorporated multiple segments (DIMS) and highly aspherical lenslets (HAL), at slowing myopia progression in a European child/adolescent population. Previous research directly comparing these designs has been limited to Chinese participants and 1-year follow-up. The prevalence of myopia in European child/adolescent has been estimated at 22.

View Article and Find Full Text PDF

Meta-regression of optic nerve imaging and visual outcome in myelin oligodendrocyte glycoprotein antibody optic neuritis.

J Neurol Sci

December 2024

Toronto Eye Specialists and Surgeons, Toronto, Ontario, Canada; Department of Ophthalmology & Vision Science, University of Toronto, Toronto, Ontario, Canada; Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; Division of Neurology, Department of Medicine, University of Toronto, Canada. Electronic address:

Background: Few predictors of visual outcome after myelin oligodendrocyte glycoprotein (MOG) auto-antibody disease optic neuritis (ON) have been reliably elucidated. We evaluate whether between-study differences in ON neuroimaging regional enhancement features may underlie heterogeneity in reported visual prognosis.

Methods: PROSPERO (CRD42024580123).

View Article and Find Full Text PDF

Introduction: Meningiomas en Plaque (MEP) represents a rare subtype, typically affecting females and seen in the fifth decade of life, with proptosis as a common presenting symptom, posing both diagnostic and surgical challenges.

Case Presentation: A 55-year-old right-handed male presented with right hemiplegia, headache, vomiting, and frequent seizures. Neurological examination showed reduced visual acuity and right-sided exophthalmos.

View Article and Find Full Text PDF

Early life stress shifts critical periods and causes precocious visual cortex development.

PLoS One

December 2024

Canadian Centre for Behavioural Neuroscience, Department of Neuroscience, University of Lethbridge, Lethbridge, AB, Canada.

The developing nervous system displays remarkable plasticity in response to sensory stimulation during critical periods of development. Critical periods may also increase the brain's vulnerability to adverse experiences. Here we show that early-life stress (ELS) in mice shifts the timing of critical periods in the visual cortex.

View Article and Find Full Text PDF

Purpose: The purpose of this study was o examine the optical coherence tomographic (OCT) characteristics of hyper-reflective foci (HRF) in patients with neovascular age-related macular degeneration (nAMD) and to assess the potential of HRF as a predictive factor for the development of macular atrophy following anti-vascular endothelial growth factor (anti-VEGF) therapy.

Methods: This was a retrospective analysis of 61 treatment-naïve eyes diagnosed with exudative AMD and type 1 macular neovascularization (MNV). The HRF was identified in the inner retina and outer retina layers, and the treatment response of HRF was documented.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!